- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04289376
Quiet Eye Duration in Baseball
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
20 subjects between 18 and 40 years of age (males and females) will participate. 10 subjects will be required to have experience in baseball or softball at the high school level or above within the last 10 years. A further 10 subjects will be recruited who did not have baseball experience at or above the high school level. Upon entering the laboratory, the experiment will be explained to the subjects. Subjects will be consented. Then, the subject's visual acuity and stereoacuity (depth perception) will be measured.
If subjects continue on to the experiment, they will also be asked to complete a short survey on previous baseball experience.
Subjects will stand in a batting stance facing a projector screen. They will then participate in trials in which they mimic batting a ball thrown by a pitcher. Six different pitch videos will be shown. The subjects will act as if they are batting the ball (no bat swing will occur) for each video. The movement of the subject's eye will be tracked using an eye tracker.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nick F Fogt, OD, PhD
- Phone Number: 6146884594 614-688-4594
- Email: fogt.4@osu.edu
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 20/20 visual acuity in each eye Stereoacuity of 40 arc seconds are better
Exclusion Criteria:
- 20/25 or worse visual acuity in either eye Stereoacuity less than 40 arc seconds
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Gaze tracking
No intervention.
Monitor gaze as subjects watch a video
|
Monitor gaze as subjects watch a video
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quiet eye duration
Time Frame: 60 minutes
|
Duration over which the gaze remains stable
|
60 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nick F Fogt, Ohio State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2019H0403
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gaze Tracking
-
Stanford UniversityUnited States Department of Defense; Department of Health and Human Services; Food and Drug Administration (FDA) and other collaboratorsTerminated
-
Stanford UniversityUnited States Department of Defense; Department of Health and Human Services; Food and Drug Administration (FDA) and other collaboratorsCompleted
-
Center for Epidemiology and Health Research, GermanyAva AGCompleted
-
Miami UniversityUnknownInterpretation Bias Modification | Symptom TrackingUnited States
-
PXL University CollegeHasselt UniversityNot yet recruitingPhysical Activity - Digital Phenotyping - Activity Tracking
-
TC Erciyes UniversityKahramanmaras Sutcu Imam UniversityCompletedDistress | Prenatal Attachment | Fetal Position TrackingTurkey
-
University of ZurichCompleted
-
University Hospital, MontpellierCompletedMyocardial Function | Echographic Parameters Obtaind by Speckle Tracking | Chilhood CancersFrance
-
Centre Hospitalier Universitaire, AmiensRecruitingFunctional Magnetic Resonance Imaging | ASD | Social Cognition | Eye Tracking | Joint AttentionFrance
-
Centre Hospitalier Universitaire, AmiensCompletedCardiac Surgery | Strains | Right Ventricle | Speckle TrackingFrance
Clinical Trials on Gaze tracking - no intervention
-
Yale UniversityCompletedAutism Spectrum DisorderUnited States
-
Centre Hospitalier Princesse GraceAssociation de Recherche Bibliographique pour les NeurosciencesCompletedParkinson Disease(PD) | Alzheimer's Dementia | Fronto-Temporal Dementia
-
Yu-Hsin HsiehChang Gung University; Jonkoping University; Folke Bernadotte Stiftelsen; Stiftelsen... and other collaboratorsCompletedCommunication Disorders | Self-Help Devices | Eye-Gaze Technology | Severe Physical DisabilitiesSweden
-
Inonu UniversityNot yet recruitingMultiple Sclerosis
-
University of Kansas Medical CenterNational Institute of Mental Health (NIMH); Children's Mercy Hospital Kansas... and other collaboratorsCompletedHIVUnited States, Kenya
-
National Institute of Neurological Disorders and...Completed
-
Butler HospitalNational Institute of Mental Health (NIMH)Completed
-
Carolyn LaucknerNational Cancer Institute (NCI)RecruitingCancer | Alcohol UseUnited States
-
Assiut UniversityNot yet recruitingAcute Coronary Syndrome | Addiction
-
Wave NeuroscienceCompletedAutistic DisorderUnited States